Revenue: The sum of all revenue fields included for a company's operating activities.
Vivos Therapeutics, Inc. (VVOS) had Revenue of $5.15M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$5.15M |
$-5.48M |
|
$2.20M |
|
$2.95M |
|
$9.98M |
|
$-4.83M |
|
$-0.70M |
|
$-5.52M |
|
$-5.52M |
|
$-5.52M |
|
$-5.52M |
|
$-5.52M |
|
$-5.52M |
|
$-4.83M |
|
$-4.31M |
|
17.68M |
|
17.68M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$4.21M |
|
$3.64M |
|
$19.93M |
|
$24.14M |
|
$20.39M |
|
$0.37M |
|
$7.74M |
|
$28.13M |
|
$-5.09M |
|
$-16.20M |
|
$-3.99M |
|
14.53M |
|
| Cash Flow Statement Financials | |
$-9.16M |
|
$-0.43M |
|
$9.34M |
|
$2.03M |
|
$1.77M |
|
$-0.26M |
|
$0.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.21 |
|
-- |
|
-- |
|
-0.10 |
|
-2.04 |
|
57.31% |
|
-93.63% |
|
-93.63% |
|
-- |
|
-107.18% |
|
-106.37% |
|
$-9.59M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
3.58 |
|
25.12 |
|
108.49% |
|
34.10% |
|
-22.88% |
|
152.57% |
|
$-0.27 |
|
$-0.54 |
|
$-0.52 |
|